The Department of Medicine

Christopher Tolleson, MD

Clinical Associate Professor
Division of Neurology

Education

Medical School
Medical College of Georgia, Augusta, GA, 2006

Residency
Neurology, UNC Chapel Hill Hospital, Chapel Hill, NC 2010

Fellowship
Movement Disorders, Vanderbilt Hospital, Nashville, TN 2011

Certifications

American Academy of Neurology
Movement Disorder Society

Current Publications

Mabrouk OS, Tichler B, Arnold HM, Thoma EC, Alexanian SM, Chen J, Liu TY, Hirschhorn B, Llorens Arenas R, Annand JW, Kapadnis U, Shomo AA, Glajch KE, et all.
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: A Phase 1 randomized controlled trial. Nat Med. 2026 Mar 24. doi: 10.1038/s41591-026-04262-4. Online ahead of print.

Safarpour D, Spindler M, Turner TH, Patel N, Vaou O, Cabrera LY, Tolleson C, Tipton PW, Aquino C, Herrington TM, Sidiropoulos C, Hantke N, Lotia M, Miocinovic S, Sharma VD, Mills KA, Wyman-Chick K, Kilbane C, Luca C, Almeida L, Rosenow J, Ooi HY, Mari Z, Luo L, Munhoz RP, Jesus S, Sarva H, Arena M, Revuelta G, Chou KL, Fasano A, Siddiqui MS, Jimenez-Shahed J; Functional Neurosurgical working group of the Parkinson Study Group.
Consensus expert recommendations for referral of Parkinson’s disease patients for deep brain stimulation surgery. NPJ Parkinsons Dis. 2026 Jan 3;12(1):30. doi: 10.1038/s41531-025-01241-3.

Christopher CJ, Morgan KH, Tolleson CM, Trudell R, Fernandez-Romero R, Rice L, Abiodun BA, Vickery Z, Jones KA, Woodall BM, Nagy C, Mieczkowski PA, Bowen G, Campagna SR, Ellis JC.
Specific bacterial taxa and their metabolite, DHPS, may be linked to gut dyshomeostasis in patients with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Nutrients. 2025 May 6;17(9):1597. doi: 10.3390/nu17091597.